How biopharmaceutical companies can leverage expert-curated knowledge from Wellcome Sanger Institute and QIAGEN to accelerate cancer drug discovery and development

Virtual - Americas - EST

The cancer drug discovery landscape is shifting. While research continues to grow in cost and complexity, the pace of development has never been faster. Biopharmaceutical companies can’t afford to waste time and resources pursuing ineffective or unsafe ideas. In this talk, our experts discuss how biopharmaceutical companies can leverage key genomic, biomedical, and clinical trial […]